FINWIRES · TerminalLIVE
FINWIRES

TPH能源公司称,美国燃料需求喜忧参半,汽油需求疲软,馏分油和出口走强。

By

-- TPH能源研究分析师马修·布莱尔(Matthew Blair)在周二的一份报告中指出,2月份美国汽油需求同比下降1.1%,较1月份2.7%的降幅有所改善,但仍落后于近期趋势。 本季度迄今为止,汽油需求下降1.9%,低于2025年第四季度1.2%的降幅以及2025年全年平均0.7%的降幅。 2月份的汽油消费量比每周预期高出约3.4万桶/日,连续第20周超出预期,但低于2025年底的修正值。 这一改善得益于车辆行驶里程增长2.6%,但墨西哥湾沿岸和西海岸地区的疲软抵消了其他地区的增长。 美国能源部的每周数据显示,汽油需求将恢复增长,3月份同比增长0.9%,4月份同比增长1.2%。 美国2月份汽油出口量增至每日98.8万桶,环比增加6000桶/日,同比增长14.2万桶/日,主要得益于对拉丁美洲和墨西哥出口量的增加。 出口量占产量的11%,高于去年同期的9%,并超出每周预期。预计3月份出口量将回落至每日88.2万桶,4月份将回落至每日86.5万桶。 馏分油需求同比增长5.4%,从1月份的下滑中反弹,推动季度平均增幅达到2.2%。 该数据比预期高出约2.8万桶/日,预计3月和4月增速将放缓至3%左右。 受馏分油和其他燃料需求的支撑,美国2月份石油总需求在1月份下滑后回升4.5%,比预期高出约11.4万桶/日。 馏分油出口量环比下降9.1万桶/日,但同比增加25万桶/日,达到114万桶/日。尽管对欧洲的出口有所下降,但整体出口量仍保持在高位,预计3月份出口量将攀升至127万桶/日,4月份将达到159万桶/日。

Related Articles

Asia

Anteris Technologies Enrolls First US Patients in PARADIGM Trial; Shares Up 6%

Anteris Technologies (ASX:AVR) has enrolled and successfully treated the first US patients in its PARADIGM global pivotal trial of the DurAVR transcatheter heart valve for severe calcific aortic stenosis, according to a Wednesday Australian bourse filing.The procedures were carried out at Montefiore Medical Center in New York, the filing added.The company's shares rose 6% in recent Wednesday trade.

$ASX:AVR
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from CAD4.20 to CAD6.40, applying a price-to-sales multiple of 13x our 2026 sales-per-share view (CAD0.49 using a USD/CAD exchange rate of 0.73x). We adjust our 2026 loss per share (LPS) estimate to -USD0.19 from -USD0.23 and our 2027 LPS view to -USD0.11 from -USD0.15. BLDP reported Q1 2026 revenue of USD19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to USD5.1M) and stationary power (up 775% to USD5.2M), though Bus revenue declined 46% to USD6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to USD52.8M, while the total backlog fell 5% to USD112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP
Research

Research Alert: CFRA Maintains Hold Rating On Shares Of Ballard Power System Inc.

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price from $3.00 to $4.70, applying a price-to-sales multiple of 13x our 2026 sales-per-share view of $0.36. We adjust our 2026 loss per share (LPS) estimate to -$0.19 from -$0.23 and our 2027 LPS view to -$0.11 from -$0.15. BLDP reported Q1 2026 revenue of $19.4M, up 26% Y/Y, driven by strong growth in rail (up 4,472% to $5.1M) and stationary power (up 775% to $5.2M), though Bus revenue declined 46% to $6.8M due to delivery timing and EU funding delays. Q1 results showed encouraging metrics, and we see potential upside from major design wins with Wrightbus and Solaris for next-generation hydrogen bus platforms and a multiyear 50 MW agreement with New Flyer. However, its declining backlog remains a concern. The 12-month order book declined 2% to $52.8M, while the total backlog fell 5% to $112.9M. We applaud improving gross margin trends, reflecting successful execution of its cost reduction initiatives.

$BLDP